Erythropoietin (Erythropoietin)


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 14.7%
Multiple Myeloma 13.2%
Antibiotic Therapy 11.8%
Product Used For Unknown Indication 10.3%
Hodgkin's Disease Stage Iii 8.8%
Infection 8.8%
Muscle Building Therapy 4.4%
Myelodysplastic Syndrome 4.4%
Renal Cell Carcinoma Stage Unspecified 4.4%
Device Therapy 2.9%
Metastatic Renal Cell Carcinoma 2.9%
Patent Ductus Arteriosus 2.9%
Anaemia 1.5%
Blood Pressure 1.5%
Hypotension 1.5%
Medical Diet 1.5%
Parenteral Nutrition 1.5%
Pneumocystis Jiroveci Infection 1.5%
Sideroblastic Anaemia 1.5%
Sudden Death 14.3%
White Blood Cell Count Decreased 14.3%
Anaemia 7.1%
Dilatation Atrial 7.1%
Glycosylated Haemoglobin Decreased 7.1%
Sepsis 7.1%
Subdural Haemorrhage 7.1%
Tachycardia 7.1%
Tooth Extraction 7.1%
Upper Gastrointestinal Haemorrhage 7.1%
Ventricular Fibrillation 7.1%
Ventricular Septal Defect 7.1%
Concomitant
Hyperphosphataemia 25.0%
Multiple Myeloma 24.5%
Renal Transplant 9.0%
Antibiotic Therapy 4.3%
Drug Use For Unknown Indication 4.3%
Fabry's Disease 4.3%
Prophylaxis Against Transplant Rejection 4.3%
Product Used For Unknown Indication 3.7%
Drug Exposure During Pregnancy 3.2%
Prophylaxis 2.7%
Haematopoietic Stem Cell Mobilisation 2.1%
Ill-defined Disorder 1.6%
Immunosuppression 1.6%
Kidney Transplant Rejection 1.6%
Myelodysplastic Syndrome 1.6%
Myocardial Infarction 1.6%
Renal And Liver Transplant 1.6%
Back Pain 1.1%
Breast Cancer 1.1%
Cardiac Failure 1.1%
Muscular Weakness 39.2%
Vomiting 10.8%
Thrombocytopenia 8.8%
Thrombotic Microangiopathy 6.9%
Tachycardia 4.9%
Renal Failure Acute 2.9%
Urosepsis 2.9%
Weight Decreased 2.9%
Blood Human Chorionic Gonadotropin Increased 2.0%
Platelet Count Decreased 2.0%
Pulmonary Fibrosis 2.0%
Renal Failure Chronic 2.0%
Sepsis 2.0%
Supraventricular Tachycardia 2.0%
Thrombocytopenia Neonatal 2.0%
Tongue Haemorrhage 2.0%
Urinary Tract Infection 2.0%
Areflexia 1.0%
Asthenia 1.0%
Back Pain 1.0%

Drug Data